Methimazole
NDC Package 64980-261-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Methimazole is used to treat overactive thyroid (hyperthyroidism). Marketed by Rising Pharmaceuticals, Inc., this product is identified by NDC 64980-261 and is authorized under FDA application ANDA202068.

Identification & Billing

NDC Package Code
64980-261-01
Package Description
100 TABLET in 1 BOTTLE
Product Code
64980-261
11-Digit Billing Format
64980026101
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA

Clinical Specifications

Proprietary Name
Methimazole
Dosage Form
-
Usage Information
Methimazole is used to treat overactive thyroid (hyperthyroidism). It works by stopping the thyroid gland from making too much thyroid hormone.

Regulatory & Marketing

Labeler Name
Rising Pharmaceuticals, Inc.
FDA Application #
ANDA202068
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
03-07-2012
End Marketing Date
09-20-2022
Listing Expiration
09-20-2022
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 64980-261-01 identifies a specific commercial package of 100 tablet in 1 bottle of Methimazole, labeled by Rising Pharmaceuticals, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Rising Pharmaceuticals, Inc. on March 07, 2012. The current certification is valid through September 20, 2022.

What are the primary indications for this medication?

Methimazole is used to treat overactive thyroid (hyperthyroidism). It works by stopping the thyroid gland from making too much thyroid hormone.

How is this Rising Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 64980026101. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
64980-261-01
11-Digit CMS (5-4-2)
64980-0261-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.